Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H32N4O2S |
Molecular Weight | 440.601 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NSC5=C4C=CC=C5
InChI
InChIKey=ZFZPJDFBJFHYIV-UHFFFAOYSA-N
InChI=1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2
Tiospirone (TSP) is an atypical antipsychotic drug. Tiaspirone appeared to be a promising antipsychotic agent as it didn`t cause extrapyramidal syndromes. It has 5HT-2 antagonistic properties as well as affinity for D2, 5HT-1a, 5HT-6 and sigma receptors. Tiospirone was in phase III clinical trials for the treatment of attention hyperactivity disorder with Mead Johnson in the USA but its development appears to have been discontinued.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL214 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11755134 |
4.65 nM [Ki] | ||
Target ID: CHEMBL225 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10991983 |
74.0 nM [IC50] | ||
Target ID: CHEMBL3371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8522988 |
950.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. | 1994 Mar |
|
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. | 1996 Jan |
|
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study. | 1998 Aug 21 |
|
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. | 2000 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2728088
After a single 75 mg dose of tiospirone, demonstrable levels of dopamine binding activity were present. A variety of time points were sampled during the multiple dose study wherein subjects received 60 mg, t.i.d. for 28 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2572973
Tiaspirone was found to be a competitive, reversible inhibitor of the sodium-dependent high-affinity choline uptake (SDHACU) by crude hippocampal and striatal synaptosomal preparations, giving IC50 values of respectively 3.69 microM and 1.14 uM.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Tiospirone
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL35057
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
C73303
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
SUB11092MIG
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
100000077236
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
87691-91-6
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
C042709
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
6035
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
55752
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
DTXSID90236558
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY | |||
|
35C6UMO5SR
Created by
admin on Sat Dec 16 17:49:25 GMT 2023 , Edited by admin on Sat Dec 16 17:49:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)